DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System, covering 2021-07-14 to 2021-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry [NA]